RXRX
Recursion Pharmaceuticals, Inc.Company with tickers: RXRX
CIK
1601830
CUSIP
75629V104
Shares Outstanding
524,677,865
13F Activity (30d)
194 filings
190 filers
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 3, 4 and 5. Form 4 must be filed within two business days of the trade.
| Date | Insider | Role | Type | Shares |
|---|---|---|---|---|
| 2026-06-05 | Gibson Christopher |
Director | Other | 40,000 |
| 2026-06-05 | Gibson Christopher |
Director | Other | 5,436 |
| 2026-06-05 | Khan Najat |
Director, CEO and President | Sell | 23,588 |
| 2026-06-05 | Gibson Christopher |
Director | Other | 1,050,567 |
| 2026-06-05 | Gibson Christopher |
Director | Other | 813,600 |
| 2026-06-05 | Gibson Christopher |
Director | Other | 399,002 |
| 2026-06-05 | Gibson Christopher |
Director | Other | 282,500 |
| 2026-06-05 | Gibson Christopher |
Director | Other | 40,000 |
| 2026-06-05 | Gibson Christopher |
Director | Other | 386,000 |
| 2026-06-05 | Gibson Christopher |
Director | Other | 388,000 |
| 2026-06-05 | Gibson Christopher |
Director | Other | 50,000 |
| 2026-06-05 | Gibson Christopher |
Director | Sell | 40,000 |
| 2026-06-05 | Gibson Christopher |
Director | Other | 666,898 |
| 2026-06-03 | Bumpus Namandje |
Director | Sell | 4,386 |
| 2026-06-02 | Borgeson Blake |
Director | Sell | 30,000 |
| 2026-05-22 | Gibson Christopher |
Director | Other | 399,002 |
| 2026-05-22 | Gibson Christopher |
Director | Other | 813,600 |
| 2026-05-22 | Gibson Christopher |
Director | Other | 50,000 |
| 2026-05-22 | Gibson Christopher |
Director | Other | 1,050,567 |
| 2026-05-22 | Gibson Christopher |
Director | Other | 386,000 |
| 2026-05-22 | Gibson Christopher |
Director | Other | 282,500 |
| 2026-05-22 | Gibson Christopher |
Director | Sell | 40,000 |
| 2026-05-22 | Gibson Christopher |
Director | Other | 666,898 |
| 2026-05-22 | Gibson Christopher |
Director | Other | 388,000 |
| 2026-05-22 | Gibson Christopher |
Director | Other | 5,436 |
| 2026-05-22 | Gibson Christopher |
Director | Other | 40,000 |
| 2026-05-22 | Gibson Christopher |
Director | Other | 40,000 |
| 2026-05-15 | Hallett David |
Chief Scientific Officer | Tax | 26,657 |
| 2026-05-15 | Gibson Christopher |
Director | Other | 386,000 |
| 2026-05-15 | Gibson Christopher |
Director | Other | 282,500 |
| 2026-05-15 | Gibson Christopher |
Director | Other | 388,000 |
| 2026-05-15 | Gibson Christopher |
Director | Other | 1,050,567 |
| 2026-05-15 | Gibson Christopher |
Director | Other | 399,002 |
| 2026-05-15 | Gibson Christopher |
Director | Tax | 22,821 |
| 2026-05-15 | Taylor Ben R |
Chief Financial Officer | Tax | 25,018 |
| 2026-05-15 | Gibson Christopher |
Director | Other | 4,343,334 |
| 2026-05-15 | Gibson Christopher |
Director | Other | 5,436 |
| 2026-05-15 | Gibson Christopher |
Director | Other | 50,000 |
| 2026-05-15 | Gibson Christopher |
Director | Other | 666,898 |
| 2026-05-15 | Gibson Christopher |
Director | Other | 813,600 |
| 2026-05-15 | Khan Najat |
Director, CEO and President | Tax | 62,701 |
| 2026-05-07 | Gibson Christopher |
Director | Other | 388,000 |
| 2026-05-07 | Gibson Christopher |
Director | Other | 60,000 |
| 2026-05-07 | Gibson Christopher |
Director | Gift | 20,000 |
| 2026-05-07 | Gibson Christopher |
Director | Other | 5,436 |
| 2026-05-07 | Gibson Christopher |
Director | Other | 666,898 |
| 2026-05-07 | Gibson Christopher |
Director | Other | 813,600 |
| 2026-05-07 | Gibson Christopher |
Director | Other | 282,500 |
| 2026-05-07 | Gibson Christopher |
Director | Other | 399,002 |
| 2026-05-07 | Gibson Christopher |
Director | Other | 60,000 |
Showing 1–50 of 2,730 transactions